About this trial
The goal of this clinical trial is to reduce diabetes distress in emerging adults (18-35 years) with type 1 diabetes and moderate-to-severe diabetes distress.
The expectation is that a group-based psychological intervention (ACTnow) will not only reduce diabetes distress but also improve psychological well-being and glycemic outcomes.
The intervention involves a multidisciplinary team, including nurses, psychologists, and physicians, and is designed in a format that can easily be integrated into future standard care.
The main research questions are:
* Does a group-based psychological intervention reduce diabetes distress? * Does a group-based psychological intervention improve psychological well-being and glycemic outcomes?
Researchers will compare the group-based psychological intervention (arm 1) with a waitlist control group, which will receive the intervention after three months (arm 2).
Participants will first attend a virtual screening interview with a psychologist or nurse to identify if they are eligible to participate in the study. After randomization, the intervention group receives six bi-weekly sessions, each lasting two hours, led by a psychologist and nurse. Each session includes a mindfulness exercise, a review of the previous session, a new topic, individual homework assignments, and a conclusion.
Eligibility criteria
Qualifiers
Type 1 diabetes for at least 6 months
Age between 18 and 35
T1-DDS score ≥ 2, or T1-DDS subscale score ≥ 2
Treated in a diabetes clinic in the Region of Southern Denmark
Disqualifiers
Psychiatric diagnosis: diagnosed with substance abuse, alcohol abuse, psychosis, schizophrenia or any other psychiatric diagnosis that may compromise participation in the intervention
Cognitive disorders such as brain injury
Complex challenges best suited to individual treatment
Current therapeutic treatment for depression, anxiety or stress
Trial design
Treatments tested in this trial
- ACTnow
Treatment groups
Sponsors and collaborators
Odense University Hospital
Lead sponsor
Steno Diabetes Center Odense
Collaborator